Transplant
Conference Coverage
‘Astonishing’ results: Skip salvage chemo, proceed to HSCT
New research on treating acute myeloid leukemia suggested that some patients may safely go straight to stem cell transplantation.
Conference Coverage
Post-transplant diet: Gruel no longer rules
New findings from Italy: Anti-bacterial diet, long the scourge of stem-cell transplant patients, doesn’t lower risk of infection.
Conference Coverage
Global effort needed to widen access to HSCT
Study findings reveal “unacceptably low” access to HSCT in some regions, triggering a call to action.
Conference Coverage
Poorly matched stem cell transplants linked to ancestry
To address disparities, medical institutions also need to improve their assessments of financial hardship.
Conference Coverage
ASH 2022: New clinical data challenge long-held assumptions
Fresh research to be unveiled at the 2022 American Society of Hematology conference seems to overturn conventional wisdom across a range of issues...
From the Journals
Transplant provides no clear survival benefit in real-world MCL study
The findings apparently contradict the survival benefit seen in clinical trial data, authors said, but are consistent with other recent...
From the Journals
Blame MCL, not transplantation, for late effects?
In patients with mantle cell lymphoma, long-term complications appeared to be caused by the disease itself, not by intensive therapy.
Bloodlines
Bias and other barriers to HSCT access
A view from the world of cellular therapy and hematopoietic stem cell transplantation.
News
First drug therapy approved for childhood GVHD
FDA greenlights ibrutinib for child blood cancer patients with chronic graft-versus-host disease.
From the Journals
Fewer transplants for MM with quadruplet therapy?
Findings bode well for quadruple drug therapy in treating newly diagnosed multiple myeloma.
Latest News
Evusheld for COVID-19: Lifesaving and free, but still few takers
“HHS hasn’t made a major educational effort to promote it.”